About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Massachusetts | 161 Studies

Clinical Trials Brain CancerMassachusetts

Brain Cancer Clinical Trials in Massachusetts

Find 161 clinical trials for brain cancer near Massachusetts. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 161 trials

RecruitingThe SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)A greater extent of resection of the contrast-enhancing (CE) tumor part has been associated with improved outcomes in high-grade glioma patients.NCT06118723·San Francisco, California and 7 others RecruitingA Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type GlioblastomaThis research study is studying troriluzole as a possible treatment for recurrent glioblastoma.NCT06552260·Boston, Massachusetts and 2 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRamucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeRATIONALE: Monoclonal antibodies, such as ramucirumab and anti-PDGFR alpha monoclonal antibody IMC-3G3 (Olaratumab), can block tumor growth in different ways.NCT00895180·Birmingham, Alabama and 10 others

CompletedBoron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the BrainRATIONALE: Radiation therapy such as boron neutron capture therapy may kill tumor cells without harming normal tissue.NCT00039572·Boston, Massachusetts and 1 other

RecruitingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsTo assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET…NCT03175224·Los Angeles, California and 34 others

TerminatedMultiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseThis study was conducted in subjects with grade IV astrocytic tumors (a type of cancer that can occur in the brain or spinal cord) in first or second relapse.NCT01068782·Birmingham, Alabama and 18 others

Active not recruitingA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaThe goal of this Phase 3 clinical trial is to compare the efficacy of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed, MGMT unmethylated…NCT06388733·Birmingham, Alabama and 94 others

CompletedBusulfan in Treating Children and Adolescents With Refractory CNS CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006246·San Francisco, California and 7 others

CompletedTipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaRATIONALE: Tipifarnib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.NCT00005859·Los Angeles, California and 10 others

UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerThe primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.NCT00045968·Birmingham, Alabama and 85 others

Active not recruitingA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study.NCT04762069·Little Rock, Arkansas and 47 others

CompletedEMD 121974 in Treating Patients With Progressive or Recurrent GliomaRATIONALE: EMD 121974 may stop the growth of cancer by stopping blood flow to the tumor.NCT00006093·Birmingham, Alabama and 9 others

CompletedAMG 595 First-in-Human in Recurrent GliomasThis is an open-label, sequential dose exploration study of single agent AMG 595 administered in subjects with recurrent glioblastoma multiforme (GBM) and/or anaplastic…NCT01475006·Los Angeles, California and 3 others

CompletedErlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaErlotinib and temsirolimus and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00112736·Los Angeles, California and 7 others

CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die.NCT00002545·Birmingham, Alabama and 259 others

CompletedZactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain TumorsPhase I: The purpose of this research study is to determine the safety of the combination treatment of ZD6474 (Vandetanib) with the standard therapy for glioblastomas and…NCT00441142·Boston, Massachusetts and 6 others

CompletedAmgen 386 for Recurrent GlioblastomaPrimary Objectives Cohort A -- monotherapy: To determine the efficacy of AMG 386 in participants with recurrent glioblastoma (GBM) as measured by 6-month progression-free…NCT01290263·Los Angeles, California and 5 others

CompletedEverolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT01062399·Newark, Delaware and 35 others

CompletedPenicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaRATIONALE: Penicillamine may stop the growth of glioblastomas by stopping blood flow to the tumor. A diet low in copper may interfere with the growth of brain tumor cells.NCT00003751·Birmingham, Alabama and 8 others

CompletedIrinotecan in Treating Patients With Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003301·Birmingham, Alabama and 8 others

PreviousPage 2 of 9Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia